Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Press Release
Apr 27, 2021
| Rachel Schwartz
AAM Statement on the Ensuring Access to Lower-Cost Medicines for Seniors Act
Press Release
Apr 22, 2021
| Rachel Schwartz
SB 764 Will Hurt Oregon's Most Vulnerable Patients
Blog
Apr 22, 2021
| Erica Klinger
Associate Member Operation Smile: A Catalyst for Increasing Access to Safe Surgery
Video
Apr 15, 2021
| Comms Temp
Adam Fein of Drug Channels to Share Insights at Access! 2021
Blog
Apr 14, 2021
| Jennifer Soup
Access! 2021 Is Coming. Here’s What You Need to Know
Fact Sheet
Mar 26, 2021
| Erica Klinger
Oppose Oregon SB 764
Press Release
Mar 25, 2021
| Rachel Schwartz
AAM Statement on IQVIA Report Examining Biosimilar Reimbursement and Adoption
Blog
Mar 25, 2021
| Craig Burton
New Analyses Point to Opportunities to Increase Savings from Biosimilar Adoption
Blog
Mar 25, 2021
| Katherine Raab
Women Continue to Make Health Policy History
Blog
Mar 23, 2021
| Craig Burton
A Roadmap for Access
Press Release
Mar 11, 2021
| Rachel Schwartz
AAM Statement on Avalere Medicare Part D Analysis
Blog
Mar 8, 2021
| Christine Simmon
Celebrating Women’s History Month
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action